Report cover image

Global Next Generation Cancer Diagnostics Market Forecast, Trends & Growth Outlook, 2025-2033

Published Jul 07, 2025
Length 380 Pages
SKU # PCSR20338828

Description

Global next generation cancer diagnostics market, valued at USD 17.74 billion in 2024, is projected to reach USD 35.51 billion by 2033, expanding at a CAGR of 8.02%.

This report explores the evolving landscape of advanced diagnostic tools, emphasizing technologies such as next-generation sequencing (NGS), qPCR and multiplexing, lab-on-a-chip (LOAC) and RT-PCR, and protein and DNA microarrays, which enable precise identification of genetic mutations, biomarkers, and circulating tumor cells (CTC).

It covers applications including biomarker development, CTC analysis, proteomic evaluation, epigenetic profiling, and genetic analysis, across cancer types like lung cancer, breast cancer, colorectal cancer, cervical cancer, and others, with functions encompassing therapeutic monitoring, companion diagnostics, prognostics, screening, and risk analysis.

Regional insights highlight North America's dominance, supported by robust R&D in the United States and Canada, while Asia-Pacific emerges as the fastest-growing area, driven by rising healthcare investments in China and India. The analysis addresses key drivers such as increasing cancer incidence, adoption of personalized medicine, and integration of AI and machine learning for enhanced accuracy, alongside challenges like high costs and regulatory complexities, with opportunities in non-invasive methods like liquid biopsies and emerging markets.

Profiles of leading companies, including Illumina Inc., F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., and Abbott Laboratories, underscore their innovations in genomic and molecular solutions for early detection and tailored therapies.

Table of Contents

380 Pages
1. Research Methodology
1.1. Desk Research
1.2. Real-time Insights and Validation
1.3. Forecast Model
1.4. Assumptions and Forecast Parameters
1.4.1. Assumptions
1.4.2. Forecast Parameters
1.5. Data Sources
1.5.1. Primary
1.5.2. Secondary
2. Executive Summary
2.1. 360° Summary
2.2. By Technology
2.3. By Application
2.4. By Cancer Type
2.5. By Function
3. Market Overview
3.1. Market Segmentation & Definitions
3.2. Key Takeaways
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.3. Porter’s Five Forces Analysis
3.3.1. Bargaining Power of Consumers
3.3.2. Bargaining Power of Suppliers
3.3.3. Threat of New Entrants
3.3.4. Threat of Substitutes
3.3.5. Competitive Rivalry in the Market
3.4. Market Dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
3.5. Technology Landscape
3.6. Regulatory Landscape
3.7. Patent Landscape
3.8. Market Value Chain Analysis
3.9. Strategic Overview
4. Global Next Generation Cancer Diagnostics Market, By Technology
4.1. Next-generation Sequencing
4.1.1. Next-generation Sequencing Market and Forecast, By Region, 2025-2033
4.1.2. Comparative Market Share Analysis, 2021 & 2033
4.2. qPCR & Multiplexing
4.2.1. qPCR & Multiplexing Market and Forecast, By Region, 2025-2033
4.2.2. Comparative Market Share Analysis, 2021 & 2033
4.3. Lab-on-a-chip (LOAC) & Reverse Transcriptase-PCR (RT-PCR)
4.3.1. Lab-on-a-chip (LOAC) & Reverse Transcriptase-PCR (RT-PCR) Market and Forecast, By Region, 2025-2033
4.3.2. Comparative Market Share Analysis, 2021 & 2033
4.4. Protein Microarrays
4.4.1. Protein Microarrays Market and Forecast, By Region, 2025-2033
4.4.2. Comparative Market Share Analysis, 2021 & 2033
4.5. DNA Microarrays
4.5.1. DNA Microarrays Market and Forecast, By Region, 2025-2033
4.5.2. Comparative Market Share Analysis, 2021 & 2033
5. Global Next Generation Cancer Diagnostics Market, By Application
5.1. Biomarker Development
5.1.1. Biomarker Development Market and Forecast, By Region, 2025-2033
5.1.2. Comparative Market Share Analysis, 2021 & 2033
5.2. CTC Analysis
5.2.1. CTC Analysis Market and Forecast, By Region, 2025-2033
5.2.2. Comparative Market Share Analysis, 2021 & 2033
5.3. Proteomic Analysis
5.3.1. Proteomic Analysis Market and Forecast, By Region, 2025-2033
5.3.2. Comparative Market Share Analysis, 2021 & 2033
5.4. Epigenetic Analysis
5.4.1. Epigenetic Analysis Market and Forecast, By Region, 2025-2033
5.4.2. Comparative Market Share Analysis, 2021 & 2033
5.5. Genetic Analysis
5.5.1. Genetic Analysis Market and Forecast, By Region, 2025-2033
5.5.2. Comparative Market Share Analysis, 2021 & 2033
6. Global Next Generation Cancer Diagnostics Market, By Cancer Type
6.1. Lung Cancer
6.1.1. Lung Cancer Market and Forecast, By Region, 2025-2033
6.1.2. Comparative Market Share Analysis, 2021 & 2033
6.2. Breast Cancer
6.2.1. Breast Cancer Market and Forecast, By Region, 2025-2033
6.2.2. Comparative Market Share Analysis, 2021 & 2033
6.3. Colorectal Cancer
6.3.1. Colorectal Cancer Market and Forecast, By Region, 2025-2033
6.3.2. Comparative Market Share Analysis, 2021 & 2033
6.4. Cervical Cancer
6.4.1. Cervical Cancer Market and Forecast, By Region, 2025-2033
6.4.2. Comparative Market Share Analysis, 2021 & 2033
6.5. Others
6.5.1. Others Market and Forecast, By Region, 2025-2033
6.5.2. Comparative Market Share Analysis, 2021 & 2033
7. Global Next Generation Cancer Diagnostics Market, By Function
7.1. Therapeutic Monitoring
7.1.1. Therapeutic Monitoring Market and Forecast, By Region, 2025-2033
7.1.2. Comparative Market Share Analysis, 2021 & 2033
7.2. Companion Diagnostics
7.2.1. Companion Diagnostics Market and Forecast, By Region, 2025-2033
7.2.2. Comparative Market Share Analysis, 2021 & 2033
7.3. Prognostics
7.3.1. Prognostics Market and Forecast, By Region, 2025-2033
7.3.2. Comparative Market Share Analysis, 2021 & 2033
7.4. Cancer Screening
7.4.1. Cancer Screening Market and Forecast, By Region, 2025-2033
7.4.2. Comparative Market Share Analysis, 2021 & 2033
7.5. Risk Analysis
7.5.1. Risk Analysis Market and Forecast, By Region, 2025-2033
7.5.2. Comparative Market Share Analysis, 2021 & 2033
8. Global Next Generation Cancer Diagnostics Market, By Region
8.1. North America
8.1.1. Market and Forecast, By Technology, 2025-2033
8.1.2. Market and Forecast, By Application, 2025-2033
8.1.3. Market and Forecast, By Cancer Type, 2025-2033
8.1.4. Market and Forecast, By Function, 2025-2033
8.1.5. Comparative Market Share Analysis, 2021 & 2033
8.1.6. U.S.
8.1.6.1. Market and Forecast, By Technology, 2025-2033
8.1.6.2. Market and Forecast, By Application, 2025-2033
8.1.6.3. Market and Forecast, By Cancer Type, 2025-2033
8.1.6.4. Market and Forecast, By Function, 2025-2033
8.1.6.5. Comparative Market Share Analysis, 2021 & 2033
8.1.7. Canada
8.1.7.1. Market and Forecast, By Technology, 2025-2033
8.1.7.2. Market and Forecast, By Application, 2025-2033
8.1.7.3. Market and Forecast, By Cancer Type, 2025-2033
8.1.7.4. Market and Forecast, By Function, 2025-2033
8.1.7.5. Comparative Market Share Analysis, 2021 & 2033
8.2. Europe
8.2.1. Market and Forecast, By Technology, 2025-2033
8.2.2. Market and Forecast, By Application, 2025-2033
8.2.3. Market and Forecast, By Cancer Type, 2025-2033
8.2.4. Market and Forecast, By Function, 2025-2033
8.2.5. Comparative Market Share Analysis, 2021 & 2033
8.2.6. Germany
8.2.6.1. Market and Forecast, By Technology, 2025-2033
8.2.6.2. Market and Forecast, By Application, 2025-2033
8.2.6.3. Market and Forecast, By Cancer Type, 2025-2033
8.2.6.4. Market and Forecast, By Function, 2025-2033
8.2.6.5. Comparative Market Share Analysis, 2021 & 2033
8.2.7. UK
8.2.7.1. Market and Forecast, By Technology, 2025-2033
8.2.7.2. Market and Forecast, By Application, 2025-2033
8.2.7.3. Market and Forecast, By Cancer Type, 2025-2033
8.2.7.4. Market and Forecast, By Function, 2025-2033
8.2.7.5. Comparative Market Share Analysis, 2021 & 2033
8.2.8. France
8.2.8.1. Market and Forecast, By Technology, 2025-2033
8.2.8.2. Market and Forecast, By Application, 2025-2033
8.2.8.3. Market and Forecast, By Cancer Type, 2025-2033
8.2.8.4. Market and Forecast, By Function, 2025-2033
8.2.8.5. Comparative Market Share Analysis, 2021 & 2033
8.2.9. Spain
8.2.9.1. Market and Forecast, By Technology, 2025-2033
8.2.9.2. Market and Forecast, By Application, 2025-2033
8.2.9.3. Market and Forecast, By Cancer Type, 2025-2033
8.2.9.4. Market and Forecast, By Function, 2025-2033
8.2.9.5. Comparative Market Share Analysis, 2021 & 2033
8.2.10. Italy
8.2.10.1. Market and Forecast, By Technology, 2025-2033
8.2.10.2. Market and Forecast, By Application, 2025-2033
8.2.10.3. Market and Forecast, By Cancer Type, 2025-2033
8.2.10.4. Market and Forecast, By Function, 2025-2033
8.2.10.5. Comparative Market Share Analysis, 2021 & 2033
8.2.11. Rest of Europe
8.2.11.1. Market and Forecast, By Technology, 2025-2033
8.2.11.2. Market and Forecast, By Application, 2025-2033
8.2.11.3. Market and Forecast, By Cancer Type, 2025-2033
8.2.11.4. Market and Forecast, By Function, 2025-2033
8.2.11.5. Comparative Market Share Analysis, 2021 & 2033
8.3. Asia Pacific
8.3.1. Market and Forecast, By Technology, 2025-2033
8.3.2. Market and Forecast, By Application, 2025-2033
8.3.3. Market and Forecast, By Cancer Type, 2025-2033
8.3.4. Market and Forecast, By Function, 2025-2033
8.3.5. Comparative Market Share Analysis, 2021 & 2033
8.3.6. China
8.3.6.1. Market and Forecast, By Technology, 2025-2033
8.3.6.2. Market and Forecast, By Application, 2025-2033
8.3.6.3. Market and Forecast, By Cancer Type, 2025-2033
8.3.6.4. Market and Forecast, By Function, 2025-2033
8.3.6.5. Comparative Market Share Analysis, 2021 & 2033
8.3.7. India
8.3.7.1. Market and Forecast, By Technology, 2025-2033
8.3.7.2. Market and Forecast, By Application, 2025-2033
8.3.7.3. Market and Forecast, By Cancer Type, 2025-2033
8.3.7.4. Market and Forecast, By Function, 2025-2033
8.3.7.5. Comparative Market Share Analysis, 2021 & 2033
8.3.8. Japan
8.3.8.1. Market and Forecast, By Technology, 2025-2033
8.3.8.2. Market and Forecast, By Application, 2025-2033
8.3.8.3. Market and Forecast, By Cancer Type, 2025-2033
8.3.8.4. Market and Forecast, By Function, 2025-2033
8.3.8.5. Comparative Market Share Analysis, 2021 & 2033
8.3.9. South Korea
8.3.9.1. Market and Forecast, By Technology, 2025-2033
8.3.9.2. Market and Forecast, By Application, 2025-2033
8.3.9.3. Market and Forecast, By Cancer Type, 2025-2033
8.3.9.4. Market and Forecast, By Function, 2025-2033
8.3.9.5. Comparative Market Share Analysis, 2021 & 2033
8.3.10. Australia
8.3.10.1. Market and Forecast, By Technology, 2025-2033
8.3.10.2. Market and Forecast, By Application, 2025-2033
8.3.10.3. Market and Forecast, By Cancer Type, 2025-2033
8.3.10.4. Market and Forecast, By Function, 2025-2033
8.3.10.5. Comparative Market Share Analysis, 2021 & 2033
8.3.11. Rest of Asia Pacific
8.3.11.1. Market and Forecast, By Technology, 2025-2033
8.3.11.2. Market and Forecast, By Application, 2025-2033
8.3.11.3. Market and Forecast, By Cancer Type, 2025-2033
8.3.11.4. Market and Forecast, By Function, 2025-2033
8.3.11.5. Comparative Market Share Analysis, 2021 & 2033
8.4. LAMEA
8.4.1. Market and Forecast, By Technology, 2025-2033
8.4.2. Market and Forecast, By Application, 2025-2033
8.4.3. Market and Forecast, By Cancer Type, 2025-2033
8.4.4. Market and Forecast, By Function, 2025-2033
8.4.5. Comparative Market Share Analysis, 2021 & 2033
8.4.6. Latin America
8.4.6.1. Market and Forecast, By Technology, 2025-2033
8.4.6.2. Market and Forecast, By Application, 2025-2033
8.4.6.3. Market and Forecast, By Cancer Type, 2025-2033
8.4.6.4. Market and Forecast, By Function, 2025-2033
8.4.6.5. Comparative Market Share Analysis, 2021 & 2033
8.4.7. Middle East
8.4.7.1. Market and Forecast, By Technology, 2025-2033
8.4.7.2. Market and Forecast, By Application, 2025-2033
8.4.7.3. Market and Forecast, By Cancer Type, 2025-2033
8.4.7.4. Market and Forecast, By Function, 2025-2033
8.4.7.5. Comparative Market Share Analysis, 2021 & 2033
8.4.8. Africa
8.4.8.1. Market and Forecast, By Technology, 2025-2033
8.4.8.2. Market and Forecast, By Application, 2025-2033
8.4.8.3. Market and Forecast, By Cancer Type, 2025-2033
8.4.8.4. Market and Forecast, By Function, 2025-2033
8.4.8.5. Comparative Market Share Analysis, 2021 & 2033
9. Company Profiles
9.1. Illumina, Inc.
9.1.1. Business Overview
9.1.2. Financial Performance
9.1.3. Product Portfolio
9.1.4. Recent Strategic Moves & Developments
9.1.5. SWOT Analysis
9.2. F. Hoffmann-La Roche Ltd
9.2.1. Business Overview
9.2.2. Financial Performance
9.2.3. Product Portfolio
9.2.4. Recent Strategic Moves & Developments
9.2.5. SWOT Analysis
9.3. QIAGEN
9.3.1. Business Overview
9.3.2. Financial Performance
9.3.3. Product Portfolio
9.3.4. Recent Strategic Moves & Developments
9.3.5. SWOT Analysis
9.4. Agilent Technologies, Inc.
9.4.1. Business Overview
9.4.2. Financial Performance
9.4.3. Product Portfolio
9.4.4. Recent Strategic Moves & Developments
9.4.5. SWOT Analysis
9.5. Abbott Laboratories
9.5.1. Business Overview
9.5.2. Financial Performance
9.5.3. Product Portfolio
9.5.4. Recent Strategic Moves & Developments
9.5.5. SWOT Analysis
9.6. Thermo Fisher Scientific Inc.
9.6.1. Business Overview
9.6.2. Financial Performance
9.6.3. Product Portfolio
9.6.4. Recent Strategic Moves & Developments
9.6.5. SWOT Analysis
9.7. GE HealthCare
9.7.1. Business Overview
9.7.2. Financial Performance
9.7.3. Product Portfolio
9.7.4. Recent Strategic Moves & Developments
9.7.5. SWOT Analysis
9.8. Medtronic
9.8.1. Business Overview
9.8.2. Financial Performance
9.8.3. Product Portfolio
9.8.4. Recent Strategic Moves & Developments
9.8.5. SWOT Analysis
9.9. BioMérieux
9.9.1. Business Overview
9.9.2. Financial Performance
9.9.3. Product Portfolio
9.9.4. Recent Strategic Moves & Developments
9.9.5. SWOT Analysis
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.